A Noble AuPtAg‐GOx Nanozyme for Synergistic Tumor Immunotherapy Induced by Starvation Therapy‐Augmented Mild Photothermal Therapy

Notwithstanding immune checkpoint blocking (ICB) therapy has made eminent clinical breakthroughs, overcoming immunologically “cold” tumors remains challenging. Here, a cascade potentiated nanomodulator AuPtAg‐GOx is engineered for boosting immune responsiveness. Upon 1064 nm laser irradiation, AuPtA...

Full description

Saved in:
Bibliographic Details
Published in:Advanced science Vol. 9; no. 31; pp. e2202332 - n/a
Main Authors: Wang, Man, Chang, Mengyu, Zheng, Pan, Sun, Qianqian, Wang, Guangqiang, Lin, Jun, Li, Chunxia
Format: Journal Article
Language:English
Published: Germany John Wiley & Sons, Inc 01-11-2022
John Wiley and Sons Inc
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Notwithstanding immune checkpoint blocking (ICB) therapy has made eminent clinical breakthroughs, overcoming immunologically “cold” tumors remains challenging. Here, a cascade potentiated nanomodulator AuPtAg‐GOx is engineered for boosting immune responsiveness. Upon 1064 nm laser irradiation, AuPtAg‐mediated mild photothermal therapy (PTT) activates cytotoxic T lymphocytes and reverses the immunogenic “cold” tumor microenvironment. Further, to amplify the thermal sensitivity of tumor cells, glucose oxidase (GOx) is introduced to suppress the production of heat shock proteins, thereby promoting mild photothermal therapy. Complementarily, AuPtAg nanozymes with catalase‐like activity can ameliorate tumor hypoxia, significantly improving the GOx activity. As a result, the combination of AuPtAg‐GOx with self‐augmented photothermal ability and PD‐L1 antibody can further escalate the antitumor efficacy. The AuPtAg‐GOx‐based synergistic starvation therapy, mild PTT, and immunotherapy cascade enhancement therapy strategy can be a favorable tool to effectively kill cancer cells. A cascade promoted AuPtAg‐glucose oxidase (GOx) nanomodulator is designed for synergistic starvation/photothermal/immunotherapy. The GOx‐mediated starvation therapy inhibits heat shock protein production for enhanced AuPtAg mediated mild photothermal therapy, which would sequentially activate the systemic immune response, prompting the tumor microenvironment to become “hot.” Therefore, AuPtAg‐GOx combined with ɑ‐PD‐1 ligand 1 could obviously inhibit tumor growth.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2198-3844
2198-3844
DOI:10.1002/advs.202202332